Abstract:Transgenic mice expressing anti‐DNA antibodies have been extensively studied as a model for understanding B cell regulation in systemic lupus erythematosus (SLE). BALB / c mice transgenic for the R4A‐γ2b heavy chain of an anti‐double‐stranded DNA (dsDNA) antibody produce two populations of high‐affinity anti‐dsDNA B cells, one deleted, and the other anergized. We generated double‐transgenic BALB / c mice expressing both the R4A‐γ2b heavy chain and the anti‐apoptotic bcl‐2 gene in the B cell compartment to stud… Show more
“…Transgenic mice that overexpress the cell survival protein bcl-2 gene develop lymphocytic infiltrates in arteries and solid organs, autoantibodies and immune complex-mediated renal disease [84]. The autoantibodies appear to be generated through inappropriate survival of autoreactive B cell clones that are normally lost through negative selection and apoptosis [84,85].…”
Section: Pathogenesis Of Lupus Nephritis: Lessons From Experimental Smentioning
A number of murine models recapitulate many of the features of systemic lupus. Spontaneous models of lupus have provided the basis for genetic linkage studies to define loci that confer an increased risk of nephritis in susceptible mice. Functional relevance of genes within susceptibility loci have been verified through the use of transgenic mice bearing targeted deletions or overexpression of candidate genes. Critical gene targets are involved in the production of autoantigens, stimulation of B cells to produce autoantibodies, stimulation of T cells to provide B cell help and cytokine-mediated damage following tissue deposition of immune complexes. In this overview, features of the commonly employed models of human lupus nephritis are reviewed. Strategies to identify candidate genes involved in the initiation and progression of lupus nephritis in these models are discussed. Finally, key studies to validate target genes as pathophysiologically relevant mediators of lupus nephritis and studies to identify potential targets for therapeutic intervention are summarized.
“…Transgenic mice that overexpress the cell survival protein bcl-2 gene develop lymphocytic infiltrates in arteries and solid organs, autoantibodies and immune complex-mediated renal disease [84]. The autoantibodies appear to be generated through inappropriate survival of autoreactive B cell clones that are normally lost through negative selection and apoptosis [84,85].…”
Section: Pathogenesis Of Lupus Nephritis: Lessons From Experimental Smentioning
A number of murine models recapitulate many of the features of systemic lupus. Spontaneous models of lupus have provided the basis for genetic linkage studies to define loci that confer an increased risk of nephritis in susceptible mice. Functional relevance of genes within susceptibility loci have been verified through the use of transgenic mice bearing targeted deletions or overexpression of candidate genes. Critical gene targets are involved in the production of autoantigens, stimulation of B cells to produce autoantibodies, stimulation of T cells to provide B cell help and cytokine-mediated damage following tissue deposition of immune complexes. In this overview, features of the commonly employed models of human lupus nephritis are reviewed. Strategies to identify candidate genes involved in the initiation and progression of lupus nephritis in these models are discussed. Finally, key studies to validate target genes as pathophysiologically relevant mediators of lupus nephritis and studies to identify potential targets for therapeutic intervention are summarized.
“…12 The transgenic heavy chain can pair with a variety of light chains to produce B-cell receptors (BCRs) with affinities for dsDNA ranging from nondetectable to high. [13][14][15] Many transgene-encoded antibodies have no detectable affinity for DNA. A population of transgene expressing B cells with low affinity for DNA is not tolerized and matures to immunocompetence in peripheral lymphoid organs 14 ; the antibodies made by this population are non-pathogenic.…”
Section: Sex Hormones and B Lymphopoiesis In Micementioning
confidence: 99%
“…Its existence has been identified in BALB/c mice transgenic for both R4A and Bcl-2 and in R4A NZB/W mice. [13][14][15] In these strains, these high-affinity autoreactive B cells mature to immunocompetence; the antibodies they secrete are pathogenic. Thus, R4A BALB/c mice possess well-characterized populations of autoreactive B cells that make them a suitable model for studying the effects of sex hormones on B-cell development.…”
Section: Sex Hormones and B Lymphopoiesis In Micementioning
The prevalence of systemic lupus erythematosus (SLE) is far higher in females than in males and numerous investigations to understand this gender bias have been performed, which propose as casual actors genetic predispositions and sex hormones effects. We will describe in this review how the sex hormones estrogen and prolactin influence B cell maturation and selection, permitting B cells to mature to immunocompetence in a mouse model of lupus. Finally, we will discuss the relevance and implications of these results for human disease.
“…In these transgenic, untreated mice, high-affinity anti-DNA B cells are rendered tolerant, and lupus does not develop [112,[209][210][211]. When subjected to a 6-week treatment with estrogen that leads to a serum concentration similar to the peak estrogen concentration during the estrus cycle (75 pg/ml), these transgenic mice develop an increased number of DNA-reactive B cells that spontaneously secrete autoantibodies, along with elevated serum anti-DNA antibody levels and glomerular IgG deposition.…”
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.